Interested in a list of relevant publications that have cited iReceptor and the AIRR Data Commons as a platform for sharing COVID-19 AIRR-seq data, check out this twitter thread by iReceptor Technical Director Brian Corrie describing the history of COVID-19 data sharing through third party publications and citations!
Sharing data is critical in fighting the #COVID19 pandemic, at @ireceptorgw we are trying to do our part. Check out the #FAIR #AIRRseq #COVID19 citation list for data curation and reuse in the @airr_community #AIRRDataCommons via the @ireceptorgw.
— Brian Corrie (@bcorrie) November 26, 2021
The list of papers citing iReceptor for COVID-19 data storage or data reuse (as of 2021-11-26) is below:
- C. Schultheiß et al., “Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease,” Immunity, vol. 53, no. 2, pp. 442-455.e4, Aug. 2020.
- J. D. Galson et al., “Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures,” Front. Immunol., vol. 11, p. 3283, Dec. 2020.
- D. Simnica et al., “Landscape of T-cell repertoires with public COVID-19-associated T-cell receptors in pre-pandemic risk cohorts,” Clin. Transl. Immunol., vol. 10, no. 9, p. e1340, Jan. 2021.
- R. R. Goel et al., “mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern,” Science (80-. )., Dec. 2021.
- A. Mohamad-Gabriel Alameh et al., “Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses,” Immunity, vol. 0, no. 0, pp. 1–16, Nov. 2021.
- P. Meysman, A. Postovskaya, N. De Neuter, B. Ogunjimi, and K. Laukens, “Tracking SARS-CoV-2 T cells with epitope-T-cell receptor recognition models,” bioRxiv, p. 2020.09.09.289355, Sep. 2020.
- M. Kuchroo et al., “Multiscale PHATE Exploration of SARS-CoV-2 Data Reveals Multimodal Signatures of Disease,” bioRxiv, p. 2020.11.15.383661, Nov. 2020.
- M. Heming et al., “Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid,” Immunity, vol. 54, no. 1, pp. 164-175.e6, Jan. 2021.
- R. A. Porritt et al., “HLA class I–associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children,” J. Clin. Invest., vol. 131, no. 10, May 2021.
- A. J. Schmitz et al., “A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants,” Immunity, vol. 54, no. 9, pp. 2159-2166.e6, Sep. 2021.
- J. Y. Humrich, J. P. Bernardes, R. J. Ludwig, D. Klatzmann, and A. Scheffold, “Phenotyping of Adaptive Immune Responses in Inflammatory Diseases,” Front. Immunol., vol. 11, p. 3010, Nov. 2020.
- F. P. Caruso, G. Scala, L. Cerulo, and M. Ceccarelli, “A review of COVID-19 biomarkers and drug targets: resources and tools,” Brief. Bioinform., vol. 22, no. 2, pp. 701–713, Mar. 2021.